RNS Number : 6257Y
BlackRock Group
02 December 2014
 



Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Nameofpersondealing(Note1)

BlackRock, Inc.

Companydealtin

Kenmare Resources PLC

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)

€0.06 ordinary shares

Dateofdealing

01 December 2014

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

219,085,277 (7.87%)

0 (0.00%)

(2)Derivatives(otherthanoptions)

12,000,000 (0.43%)

0 (0.00%)

(3)Optionsandagreementstopurchase/sell

0 (0.00%)

0 (0.00%)

Total

231,085,277 (8.30%)

0 (0.00%)

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Classofrelevantsecurity:

Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities



 

(2)Derivatives(otherthanoptions)



 

(3)Optionsandagreementstopurchase/sell



Total




Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(Note5)

Sale

235,000

GBP 0.0532

Sale

400,000

GBP 0.0535

Sale

100,000

GBP 0.0556

Sale

20,833

GBP 0.0557

   

(b)      Derivatives transactions (other than options transactions)

 

Productname,

e.g.CFD

Natureoftransaction

(Note6)

Numberofrelevantsecurities

(Note7)

Priceperunit

(Note5)





   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing,selling, purchasing or varying

 

Productname,

e.g.calloption

Writing,selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates(Note7)

Exercise price

Type,e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit(Note5)








 

(ii)      Exercising

 

Productname,

e.g.calloption

Numberofsecurities

Exercisepriceper unit(Note5)




 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Natureoftransaction

(Note8)

Details

Priceperunit

(if applicable) (Note 5)




   


Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, 

this should be stated.

 

 

 

                                                                                                                None

 

 

 

Is a Supplemental Form 8 attached?(Note 9)                                            YES

 

Dateofdisclosure

02 December 2014

Contactname

Gareth Slade

Telephonenumber

+44 20 7743 2536

IfaconnectedEFM,nameofofferee/offerorwithwhichconnected


IfaconnectedEFM,statenatureofconnection(Note10)


 



 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i),Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS(Note 1)

 

Productname,

e.g.calloption

Written,orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price(Note2)

Type,e.g.American,Europeanetc.

Expiry date

Warrant

N/A

12,000,000

N/A

N/A

16/11/2019

 

Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

              Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts,the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEFMMGZFZNGDZM